U.S. Patient Temperature Management Market Size, Share & Trends Analysis Report By Type (Warming Systems, Cooling Systems), By Application (General Surgery, Cardiology), By End-use, And Segment Forecasts, 2024 - 2030

Market Size & Trends

The U.S. patient temperature management market size was estimated at USD 1.30 billion in 2023 and is expected to exhibit a CAGR of 7.3% from 2024 to 2030. The market is substantially growing due to increased surgical procedures. This surge is attributed to several factors, including advancements in medical technology, an aging population, increasing number of hypothermia cases and an increasing prevalence of chronic diseases requiring surgical intervention. For instance, according to the Population Reference Bureau (PRB), the population of Americans aged 65 and above is expected to grow from 58 million (2022) to 82 million by 2050, marking a 47% increase. In addition, the proportion of this age group in the total population is projected to rise from 17% to 23%. Overall, the rise in the number of surgical procedures, coupled with the growing emphasis on patient safety and outcomes, is fueling the market growth.

Patients undergoing cancer treatment, such as chemotherapy or radiation therapy, often experience fluctuations in body temperature as a result of treatment side effects, immune system suppression, or the cancer itself. According to the National Cancer Institute, hyperthermia, also known as thermal therapy or thermotherapy, is a treatment method that involves heating body tissues up to temperatures as high as 113 °F. This approach aims to damage and eliminate cancer cells while minimizing harm to healthy tissue. Effective temperature management is essential during cancer treatment to mitigate the risk of fever, hypothermia, or other temperature-related complications. For instance, according to the American Cancer Society (ACS) in January 2024, the anticipated number of new cancer cases in the U.S. is projected to surpass 2 million, translating to nearly 5,500 new cancer diagnoses each day.

Maintaining optimal body temperature is critical for successful outcomes in cardiac surgeries, catheterization procedures, and other cardiovascular interventions. According to data from the CDC, in 2022, approximately 20.1 million U.S. adults have coronary artery disease, and 805,000 Americans have a heart attack each year. The upward trend in these figures is linked to the growing prevalence of preventive cardiac surgeries conducted each year.

Market Concentration & Characteristics

Advancements in technology have led to the development of sophisticated patient temperature management devices, such as advanced warming blankets, forced-air warming systems, and intravascular temperature management systems. These devices offer improved precision, efficiency, and patient comfort compared to traditional methods.

Moreover, the integration of smart technologies, such as wireless connectivity and remote monitoring capabilities, has enabled healthcare providers to monitor and regulate patient temperature more effectively. For instance, according to SAE Media Group in June 2022, Lincoln Laboratory's new device monitors trainees' core body temperature during training, alerting them to potential injury risks via a smartwatch display. It uses an armband sensor to measure heart rate, transmitting data to the smartwatch via Bluetooth.  

Several key players are undertaking various initiatives such as mergers & acquisitions and collaborations to expand business portfolio. For instance, in January, SourceMark announced a partnership with Gentherm Medical, a well-known manufacturer of systems for controlling patient temperature. Building on their previous collaboration, SourceMark is now the U.S. distributor for a few Gentherm patient warming product lines.

Type Insights

Based on type, the patient warming systems segment led the market with the largest revenue share of 54.0% in 2023. This is due to their frequent usage during surgeries involving general anesthesia. General anesthesia provided before surgery lowers the patient’s body temperature. Hence, pre-warming of the patient’s body before surgery is required, thereby reducing the risk of perioperative hypothermia.

The dual technology segment is anticipated to grow at the fastest CAGR of 9.4% over the forecast period. This technology offers a comprehensive approach to maintaining normothermia or achieving therapeutic hypothermia in patients undergoing multiple medical procedures. This integrated approach enhances the efficiency and effectiveness of temperature management, contributing to improved patient outcomes and enhanced comfort during critical care, surgery, or recovery periods. Additionally, dual technology solutions are designed to be adaptable and customizable to meet the specific needs of individual patients and clinical environments. For instance, as per a research article published by NCBI in 2023, the dual sensor approach incorporated into a wearable chest patch sensor offers precise and reliable temperature readings across a wide range of patient demographics.

Application Insights

Based on application, the general surgery segment led the market with the largest revenue share in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. Factors supporting this growth include rising number of cardiac and gynecology surgeries. For instance, as per National Institute of Health’s article, an estimated 2 million open heart surgeries are performed around the world. Temperature management systems are also largely used in pre, post, and perioperative surgical procedures. In addition, these devices help address surgical site complications.

The cardiology segment is expected to witness a significant CAGR during the forecast period, due to the increasing prevalence of cardiovascular diseases. According to The Heart Foundation, in the U.S., every year, around 720,000 people suffer from heart attacks. Cardiac diseases, such as stroke and heart attack, need cold temperatures for eliminating any risk of traumatic brain injuries, thereby generating high demand for cooling devices in the country.

End-use Insights

Based on end-use, the operating room segment led the market with the largest revenue share in 2023. During different stages of surgeries, patients require specific temperatures within the operating room to reduce surgical complications. For example, patients undergoing cardiac surgeries often require cooling therapies, however, patients who are given anesthesia before surgery need warming therapies. Thus, with the surge in surgeries, the demand for these products is expected to remain high.

The neonatal care segment is estimated to offer lucrative opportunities due to the rising number of childbirth and premature deliveries, requiring huge support with temperature management devices in neonatal care. Moreover, there is a risk of hypothermia in premature infants as they are exposed to cold temperatures in neonatal care. Hence, they are kept warm using patient warming systems in neonatal care.

Key U.S. Patient Temperature Management Company Insights

Companies are focusing on strategic initiatives, such as the introduction of novel products through customization according to consumers’ needs, partnerships, collaborations, and mergers & acquisitions, to expand their product portfolio and extend leadership positions in the field of cardiology field. Moreover, the competition between key players will turn intense in the coming years as they are focusing more on geographical expansion, strategic collaborations, and partnerships through mergers & acquisitions.

Recent Developments

• In January, 2024, SourceMark announced a partnership with Gentherm Medical, a well-known manufacturer of systems for controlling patient temperature. Building on their previous collaboration, SourceMark is now the U.S. distributor for a few Gentherm patient warming product lines. traditional Arrow Midline, both of which come in single & double lumen options.

• In June, 2023, Drägerwerk AG & Co. KGaA introduced the FDA-cleared Babyroo TN300, an open warmer providing supportive lung protection and temperature stability. It facilitates clinician access to routine care, emergencies, and procedures during the baby’s hospital stay while promoting family-centered care for healthy outcomes.

• In July, 2024, Gentherm acquired Jiangmen Dacheng Medical Equipment Co., Ltd., which produced patient temperature control systems and other medical supplies & equipment.

U.S. Patient Temperature Management Market Report Scope

U.S. Patient Temperature Management Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. patient temperature management market report based on type, application, and end-use:

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Patient Warning Systems

    • Conventional Warning Systems

      • Blankets

      • Pads

    • Surface Warning Systems

      • Warming Systems

      • Blankets

      • Pads

    • Others

      • Open-basin

      • Fluid Warmers

  • Patient Cooling Systems

    • Conventional Cooling Systems

      • Blankets

      • Pads

    • Surface Cooling Systems

      • Cooling Systems

      • Blankets

      • Pads

    • Others

  • Dual Technology

    • Surface Warming Systems

    • Intravascular Warming Systems

  • Consumables

    • Irrigation Drapes

    • Fluid Warmer Drapes

    • Scope Warmer Drapes

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • General Surgery

  • Cardiology

  • Pediatrics

  • Neurology

  • Orthopedic Surgery

  • Thoracic Surgery

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Operating rooms

  • Neonatal ICU

  • ICUs

  • Emergency room

  • Preoperative Care Units

  • Postoperative Care Units

  • Acute Care

  • Burn Centers

  • Cath Labs

  • Neurological Care Units

  • Others